Gastric cancer
Conditions
Interventions
Study group:Individualized chemotherapy
Sponsors
Nanjing Drum Tower Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. 18 years of age or older; 2. Histologically or cytologically confirmed gastric cancer patients; 3. With malignant ascites; 4. Have tumor sample for individual test; 5. ECOG =1.5*10^9/L; (2) Hemoglobin >=10g/dL; (3) Platelet count >=100*10^9/L; 8. No chemotherapy contraindications; (1) Total bilirubin =60ml/min; 9. Patients of childbearing age should take appropriate protective measures before and in the experiment; 10. Signed informed consent; 11. Be able to follow the research plan and follow-up process.
Exclusion criteria
Exclusion criteria: 1. Patients with chemotherapy history; 2. The patient has a history of other tumors, unless the cervical carcinoma in situ, the treatment of the cancer or bladder epithelial tumor (Ta and TIS), or other has accepted the radical treatment of malignant tumor (at least 5 years before); 3. Patients with active bacterial or fungal infection (>=level 2 of NCI-CTC; 4. Patients with HIV infection, HCV infection, uncontrollable coronary artery disease or asthma, and other diseases can not be in the group of patients of cerebral vascular disease or uncontrolled thought; 5. Pregnancy, breast-feeding women; 6. Drug abuse, psychological or social factors of clinical or the implementation of informed consent or affected; 7. Patient with potential drug allergy; 8. Can not accept chemotherapy; 9. significant weight loss within 6 weeks before into the trail; 10. Any affect safety or compliance of patients with uncertain factors; 11. Contraindications to hormone use.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate;Progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Contacts
Public ContactLiu Baorui
Outcome results
None listed